Cytosorbents (CTSO) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CTSO Cytosorbents

Watchlist

0.910
-0.030-3.20%

Trading May 23 09:50 ET

49.41MMarket Cap-1542P/E (TTM)

Intraday

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

B. Riley Securities Reiterates Buy on CytoSorbents, Maintains $3 Price Target
B. Riley Securities analyst Yuan Zhi reiterates CytoSorbents (NASDAQ:CTSO) with a Buy and maintains $3 price target.
BenzingaMay 15 10:06 ET
Cytosorbents First Quarter 2024 Earnings: In Line With Expectations
Yahoo FinanceMay 12 09:03 ET
Earnings Call Summary | Cytosorbents(CTSO.US) Q1 2024 Earnings Conference
The following is a summary of the Cytosorbents Corporation (CTSO) Q1 2024 Earnings Call Transcript:Financial Performance:Cytosorbents Corporation experienced a 14% increase in product sales in Q1 2024
moomoo AIMay 10 09:57 ET · Conference Call
CytoSorbents Q1 2024 GAAP EPS $(0.12), Inline, Sales $9.787M Beat $9.785M Estimate
CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 29.41 percent increase over losses of $(0.17) per share from the same peri
BenzingaMay 9 17:19 ET
Cytosorbents | 10-Q: Quarterly report
Futu NewsMay 9 17:02 ET · Announcements
CytoSorbents: Q1 Earnings Snapshot
BarchartMay 9 16:24 ET

Comments

Jaguar8

May 2 06:08

$Cytosorbents(CTSO.US)$
NEWS
CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe

Moomoo AI

Dec 28, 2023 13:41

Despite promising growth forecasts, investor sentiment appears reserved, as revealed in the company's P/S ratio. Additionally, the recent stock price surge didn't significantly affect the P/S ratio, implying tempered revenue expectations. The high-growth yet low P/S ratio raises caution in market.